Infection and infectious diseases, Planning

Carsirivimab + imdevimab

26 December 2020dm+d: Unassigned

CP101

4 December 2020dm+d: Unassigned

Obiltoxaximab

11 November 2020dm+d: Unassigned

Lenacapavir

1 October 2020dm+d: Unassigned

Nirsevimab

19 September 2020dm+d: Unassigned

Ansuvimab

31 July 2020dm+d: Unassigned

COVID-19 vaccines in development

17 June 2020dm+d: Unassigned

Grazoprevir

14 March 2020dm+d: Unassigned

Doravirine + islatravir

10 March 2020dm+d: Unassigned